Skip to content

Clinical trials

Phase 1 Retinitis Pigmentosa trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Retinitis Pigmentosa Phase: Phase 1 Country / region: United States Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20071
20091
20123
20171
20191
20212
20221
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting4
Recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Johns Hopkins University3
National Eye Institute (NEI)2
QLT Inc.2
University of California, Davis2
Cedars-Sinai Medical Center1
Centocor, Inc.1
Ray Therapeutics, Inc.1
The Foundation for Orthopaedics and Regenerative Medicine1
University of Rochester1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Retinitis Pigmentosa14
Diabetic Retinopathy2
Leber Congenital Amaurosis2
Macular Degeneration2
Retinal Degeneration2
Retinal Diseases2
Alcoholism1
Choroideremia1
Eye Diseases1
Optic Atrophy1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.